MGH To Lead Major National Study Of Bipolar Disorder

October 20, 1998

The Massachusetts General Hospital (MGH) has been chosen by the National Institute of Mental Health as the coordinating center for a national research study into the treatment of bipolar disorder, more commonly called manic-depressive disorder. The study will be supported by a five-year grant of more than $20 million, making it the largest psychiatric clinical research program undertaken anywhere.

The MGH team, led by Gary Sachs, MD, the study's principal investigator, will collaborate with investigators at the University of Pittsburgh, the University of Colorado and nine other centers in a program designed to evaluate existing treatment protocols and speed the process by which treatments are tested and introduced into clinical practice. The goals include improving the diagnosis of patients, testing new medications for bipolar disorder and determining which treatment plans work best for patients in particular situations, and building an informational and organizational structure for future research.

"Our being chosen to lead this project is a tremendous honor," says Edwin H. Cassem, MD, chief of the MGH Department of Psychiatry. "The outstanding work of Dr. Sachs and his colleagues in the MGH Bipolar Program now will be a model for an effort that will improve the care of patients everywhere." The MGH team also includes investigators from McLean Hospital, Brigham and Women's Hospital (BWH) and Harvard Medical School (HMS).

People with bipolar disorder experience extreme mood swings, from excessive "highs" called mania to the dark "lows" of depression. According to the National Depressive and Manic Depressive Association, more than 2 million Americans have bipolar disorder, and as many as two-thirds are undiagnosed, misdiagnosed or poorly treated for a condition that can be life-threatening.

"Without proper treatment, 15 to 20 percent of people with bipolar disorder will die by suicide," says Sachs. "When appropriately treated, their risk is no greater than that of the general population. And treatment also can make a huge difference in people's lives by alleviating symptoms that could ruin their careers and their relationships."

Sachs adds that people with bipolar disorder sometimes are misdiagnosed with depression only (unipolar depression) which may lead to inappropriate treatment, or they may have more subtle symptoms that do not initially look like classic bipolar disorder. "To correctly diagnose this illness, you need to look at the whole spectrum of the patient's moods and behaviors, not just the current episode. That usually means involving a patient's family members and friends, who can help paint a complete picture of what is happening in the patient's life."

Medications available to treat bipolar disorder, primarily lithium and more recently certain anticonvulsant drugs, enable many patients to return to productive lives but are not perfect. Some patients' symptoms improve but do not disappear; others may not respond to any currently approved medication. In addition, patients who remain symptom-free for extended periods of time may be tempted to stop their medication, putting them at risk for relapse.

New medications on the horizon may prove more useful for bipolar patients. In addition, several types of individual and group psychotherapy can provide crucial help and support to bipolar patients and to their family and friends. The challenge facing physicians and patients today is determining which combination of medications, therapy and other interventions would best meet the needs of each individual patient.

"There are about two dozen potential new drugs out there," says Sachs. "Evaluating each of them in separate studies at a lot of different centers would be complex and very time-consuming. This project will establish a framework for coordinated testing of these medications and for quickly sharing new information from the project's research or from studies conducted elsewhere. By basing this project in clincial facilities around the country, we should get a clearer picture of how well particular treatment approaches actually work in real-world situations."

The project will establish 12 treatment centers across the country, at the MGH, Pittsburgh, Colorado and nine additional centers to be chosen in the coming months. The centers' staff psychiatrists and clinical specialists will be trained in the use of diagnostic techniques and treatment guidelines developed within the MGH Bipolar Program. Along with adopting these guidelines, the treatment centers will gather and share data about treatment outcomes in consenting patients and offer patients the opportunity to participate in clinical trials of new medications and treatment protocols.

"Simply implementing the treatment guidelines, which have been supported by national and international experts, should improve the care of about 5,000 patients at the participating centers," Sachs says. "As we refine and improve those guidelines, develop new ones based on studies of new treatments, and share that information with the wider psychiatric community, we hope to impact the care of tens of thousands of patients in the United States and around the world."

Key members of the MGH research team include Lee Cohen, MD, Christina Demopulos, MD, Andrew Nierenberg, MD, Michael Otto, PhD, Mark Pollack, MD, Noreen Reilly-Harrington, MD, and Adele Viguera, MD, at the MGH; Andrew Stoll, MD, at BWH; Ross Baldessarini, MD, John Hennen, PhD, and Roger Weiss, MD, at McLean Hospital; and Richard Frank, PhD, at HMS.
-end-


Massachusetts General Hospital

Related Mental Health Articles from Brightsurf:

Mental health strained by disaster
A new study found that suicide rates increase during all types of disasters -- including severe storms, floods, hurricanes and ice storms -- with the largest overall increase occurring two years after a disaster.

The mental health impact of pandemics for front line health care staff
New research shows the impact that pandemics have on the mental health of front-line health care staff.

World Mental Health Day -- CACTUS releases report of largest researcher mental health survey
On the occasion of 'World Mental Health Day' 2020, CACTUS, a global scientific communications company, has released a global survey on mental health, wellbeing and fulfilment in academia.

Mental illness, mental health care use among police officers
A survey study of Texas police officers examines how common mental illness and mental health care use are in a large urban department.

COVID-19 outbreak and mental health
The use of online platforms to guide effective consumption of information, facilitate social support and continue mental health care delivery during the COVID-19 pandemic is discussed in this Viewpoint.

COVID-19 may have consequences for mental health
The COVID-19 pandemic appears to be adversely affecting mental health among hospitalised patients, the healthcare professionals treating them and the general population.

Mental health outcomes among health care workers during COVID-19 pandemic in Italy
Symptoms of posttraumatic stress disorder, depression, anxiety and insomnia among health care workers in Italy during the COVID-19 pandemic are reported in this observational study.

Mental ill health 'substantial health concern' among police, finds international study
Mental health issues among police officers are a 'substantial health concern,' with around 1 in 4 potentially drinking at hazardous levels and around 1 in 7 meeting the criteria for post traumatic stress disorder and depression, finds a pooled data analysis of the available international evidence, published online in Occupational & Environmental Medicine.

Examining health insurance nondiscrimination policies with mental health among gender minority individuals
A large private health insurance database was used to examine the association between between health insurance nondiscrimination policies and mental health outcomes for gender minority individuals.

Mental health care for adolescents
Researchers examined changes over time in the kinds of mental health problems for which adolescents in the United States received care and where they got that care in this survey study with findings that should be interpreted within the context of several limitations including self-reported information.

Read More: Mental Health News and Mental Health Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.